Literature DB >> 8577544

Clinical significance of resolution of chest X-ray findings in HIV-infected children with lymphocytic interstitial pneumonitis (LIP).

M Prosper1, J A Omene, J C Odita.   

Abstract

Lymphocytic interstitial pneumonitis (LIP) in HIV-infected children is generally associated with better prognosis as compared with children with Pneumocystis carinii pneumonia (PCP). We prospectively studied 12 cases of HIV-infected children with LIP over a 4-year period in an effort to document one aspect of the natural history of this clinical entity. Severe CD4 lymphocytopenia was associated with complete resolution of the chest X-ray findings in five patients, one of whom died of disseminated Mycobacterium avium complex. A second patient developed rapid-onset subacute HIV encephalopathy at the time when the CD4-lymphocyte count declined from 589 to 39, and the lung findings resolved spontaneously. The resolution of the lung pathology may be the first indication of severe immune suppression and a warning of the increased risk for opportunistic infections. Therefore, in those settings where diagnostic laboratory facilities are not easily available, the resolution of the reticulonodular changes on chest radiographs is a poor prognostic sign in HIV-infected children with LIP.

Entities:  

Mesh:

Year:  1995        PMID: 8577544

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  2 in total

1.  Pneumothorax as the presenting sign of Pneumocystis carinii infection in an HIV-positive child with prior lymphocytic interstitial pneumonitis.

Authors:  K S Solomon; T L Levin; W E Berdon; B Romney; C Ruzal-Shapiro; M R Bye
Journal:  Pediatr Radiol       Date:  1996

2.  Pathogenesis of simian immunodeficiency virus pneumonia: an immunopathological response to virus.

Authors:  J L Mankowski; D L Carter; J P Spelman; M L Nealen; K R Maughan; L M Kirstein; P J Didier; R J Adams; M Murphey-Corb; M C Zink
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.